As to other components of the PI3K/Akt/mTOR signaling pathway, p85α PI3K has been demonstrated to be involved in oncogenic c-Kit-induced transformation in AML, in an murine model where p85α PI3K expression was disrupted in HSCs. The gene discussed is KIT; the disease is acute myeloid leukemia.